Difference between revisions of "Template:Ionotropic glutamate receptor modulators"
Jump to navigation
Jump to search
imported>Medgirl131 |
imported>Medgirl131 |
||
| Line 289: | Line 289: | ||
* [[ZD-9379]]; ''Ifenprodil (NR2B) site antagonists:'' | * [[ZD-9379]]; ''Ifenprodil (NR2B) site antagonists:'' | ||
* [[Besonprodil]] | * [[Besonprodil]] | ||
| + | * [[CO-101244|CO-101244 (PD-174494)]] | ||
* [[Eliprodil]] | * [[Eliprodil]] | ||
* [[Haloperidol]] | * [[Haloperidol]] | ||
| Line 294: | Line 295: | ||
* [[Ro 25-6981]] | * [[Ro 25-6981]] | ||
* [[Safaprodil]] | * [[Safaprodil]] | ||
| − | * [[Traxoprodil]] | + | * [[Traxoprodil]]; ''Other NR2B-selective antagonists:'' [[Isoxsuprine]] |
| − | |||
| − | |||
| − | ''NR2B | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
* [[Nylidrin]] | * [[Nylidrin]] | ||
* [[Rislenemdaz|Rislenemdaz (CERC-301, MK-0657)]] | * [[Rislenemdaz|Rislenemdaz (CERC-301, MK-0657)]] | ||
| − | * [[ | + | * [[Ro 8-4304]]; ''Polyamine site antagonists:'' [[Arcaine]] |
| − | |||
| − | |||
* [[Co 101676]] | * [[Co 101676]] | ||
* [[1,3-Diaminopropane|Diaminopropane]] | * [[1,3-Diaminopropane|Diaminopropane]] | ||
| Line 340: | Line 331: | ||
| below = '''''See also:''' [[Template:Receptor modulators|Receptor/signaling modulators]] • [[Template:Metabotropic glutamate receptor modulators|Metabotropic glutamate receptor modulators]] • [[Template:Glutamate metabolism and transport modulators|Glutamate metabolism/transport modulators]]'' | | below = '''''See also:''' [[Template:Receptor modulators|Receptor/signaling modulators]] • [[Template:Metabotropic glutamate receptor modulators|Metabotropic glutamate receptor modulators]] • [[Template:Glutamate metabolism and transport modulators|Glutamate metabolism/transport modulators]]'' | ||
| − | }}<noinclude> | + | }} |
| + | <noinclude> | ||
{{collapsible option}} | {{collapsible option}} | ||
[[Category:Drug templates by receptor, channel, or pump]] | [[Category:Drug templates by receptor, channel, or pump]] | ||
</noinclude> | </noinclude> | ||
Revision as of 22:17, 2 September 2017
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Ionotropic glutamate receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Ionotropic glutamate receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Ionotropic glutamate receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.